Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)

Urs E. Studer,Laurence Collette,Peter Whelan,Walter Albrecht,Jacques Casselman,Theo de Reijke,Hartmut Knönagel,Wolfgang Loidl,Santiago Isorna,Subramanian K. Sundaram,Muriel Debois

European Urology（2008）

引用 142|浏览10

暂无评分

摘要

In EORTC trial 30891, patients without local curative treatment for prostate cancer with baseline PSA<50ng/ml and PSADT>12 mo were likely to die of unrelated causes; thus they may be spared the burden of immediate ADT.

查看译文

关键词

Androgen deprivation,Deferred treatment,Prostate cancer,Survival,PSA doubling time

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要